Skip to main content

Table 7 Summary of subjects with any AE by preferred term (safety set)

From: Efficacy of N,N‘bis-(2-mercaptoethyl) isophthalamide on mercury intoxication: a randomized controlled trial

 

Number (%) of subjects

Preferred term

NBMI 100 mg (n = 13)

NBMI 300 mg (n = 11)

Placebo (n = 12)

Total (n = 36)

Number of subjects with any AE*

6 (46.2%)

5 (45.5%)

8 (66.7%)

19 (52.8%)

Headache

5 (38.5%)

3 (27.3%)

4 (33.3%)

12 (33.3%)

Abdominal pain upper

1 (7.7%)

1 (9.1%)

2 (16.7%)

4 (11.1%)

Abdominal pain

 

1 (9.1%)

2 (16.7%)

3 (8.3%)

Diarrhoea

1 (7.7%)

 

1 (8.3%)

2 (5.6%)

Somnolence

1 (7.7%)

 

1 (8.3%)

2 (5.6%)

Animal bite

 

1 (9.1%)

 

1 (2.8%)

Arthralgia

  

1 (8.3%)

1 (2.8%)

Back pain

  

1 (8.3%)

1 (2.8%)

Ear pain

1 (7.7%)

  

1 (2.8%)

Gastroenteritis

1 (7.7%)

  

1 (2.8%)

Ingrowing nail

1 (7.7%)

  

1 (2.8%)

Insomnia

  

1 (8.3%)

1 (2.8%)

Lip dry

  

1 (8.3%)

1 (2.8%)

Oropharyngeal pain

  

1 (8.3%)

1 (2.8%)

Vertigo

  

1 (8.3%)

1 (2.8%)